Cargando…
PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum
BACKGROUND/AIMS: Adenocarcinoma of the rectum (READ) is typically diagnosed at advanced stages due to a lack of early-onset specific features. MATERIALS AND METHODS: The study used bioinformatics analysis of READ ribonucleic acid sequencing data from The Cancer Genome Atlas database to identify diff...
Autor principal: | Xie, Keju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645281/ https://www.ncbi.nlm.nih.gov/pubmed/37737218 http://dx.doi.org/10.5152/tjg.2023.23189 |
Ejemplares similares
-
PHLPP2 as a novel metastatic and prognostic biomarker in non‐small cell lung cancer patients
por: Wang, Hongmei, et al.
Publicado: (2019) -
High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma
por: Lv, Dongqing, et al.
Publicado: (2015) -
Prognostic and Predicted Significance of FENDRR in Colon and Rectum Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2021) -
Chondrocytic and pharmacokinetic properties of Phlpp inhibitors
por: Taylor, E.L., et al.
Publicado: (2021) -
Aberrant Expression of PHLPP1 and PHLPP2 Correlates with Poor Prognosis in Patients with Hypopharyngeal Squamous Cell Carcinoma
por: Zhou, Jieyu, et al.
Publicado: (2015)